All lobbying filings

The McManus Group

The McManus Group filed a Q3 report for Dendreon Pharmaceuticals LLC on October 20, 2025, reporting $30,000 in lobbying income.

Lobbying for Dendreon Pharmaceuticals LLC · Biopharmaceutical company.

As filed: THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC.

All filings by The McManus Group · Everything Dendreon Pharmaceuticals LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

JOHN MCMANUS

Previously held: LA, Bill Thomas. Staff Director, W&M Health Subcommittee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.

Veterans

Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.